Inventor profile of:

David Charles Rees

City:

Cambridge

Country:

United Kingdom

Published Applications:

25

Last publication date:

2025-03-20

Top Assignees for applications by David Charles Rees

The entities that hold a legal rights for patent applications filed by inventor Rees David Charles:

Recent patent applications by Rees David Charles

David Charles Rees from Cambridge, GB has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-03-20
US20250092027A1
Chemistry; metallurgy

ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY

#2 | 2022-05-05
US20220135544A1
Chemistry; metallurgy

PYRAZOLYL QUINOXALINE KINASE INHIBITORS

#3 | 2022-04-07
US20220106287A1
Chemistry; metallurgy

ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY

#4 | 2022-03-01
US16680969
Chemistry; metallurgy

Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity

#5 | 2021-09-09
US20210276984A1
Chemistry; metallurgy

Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity

#6 | 2020-08-06
US20200247789A2
Chemistry; metallurgy

ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY

#7 | 2020-04-30
US20200131153A1
Chemistry; metallurgy

PYRAZOLYL QUINOXALINE KINASE INHIBITORS

#8 | 2020-03-12
US20200079761A1
Chemistry; metallurgy

Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity

#9 | 2019-02-21
US20190055215A1
Chemistry; metallurgy

Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity

#10 | 2019-01-17
US20190016708A1
Chemistry; metallurgy

Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity

#11 | 2018-05-10
US20180127397A1
Chemistry; metallurgy

Pyrazolyl quinoxaline kinase inhibitors

#12 | 2016-10-27
US20160311800A1
Chemistry; metallurgy

Pyrazolyl quinoxaline kinase inhibitors

#13 | 2016-03-24
US20160083377A1
Chemistry; metallurgy

Bicyclic heterocycle compounds and their uses in therapy

#14 | 2015-04-16
US20150105368A1
Chemistry; metallurgy

Pyrazolyl quinoxaline kinase inhibitors

#15 | 2014-09-25
US20140288040A1
Human necessities

SUBSTITUTED BENZYLAMINE COMPOUNDS, THEIR USE IN MEDICINE, AND IN PARTICULAR THE TREATMENT OF HEPATITIS C VIRUS (HCV) INFECTION

#16 | 2014-02-13
US20140045831A1
Human necessities

Bicyclic heterocycle compounds and their uses in therapy

#17 | 2013-03-21
US20130072457A1
Chemistry; metallurgy

Pyrazolyl quinoxaline kinase inhibitors

#18 | 2012-07-26
US20120190673A1
Chemistry; metallurgy

Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases

#19 | 2011-11-10
US20110274616A1
Chemistry; metallurgy

4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors

#20 | 2011-11-03
US20110269808A1
Human necessities

Compositions comprising (S)-2-amino-1-(4-chlorophenyl)-1-[4-(1H-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinases

#21 | 2010-05-06
US20100113551A1
Human necessities

COMPOSITIONS COMPRISING (S)-2-AMINO-1-(4-CHLOROPHENYL)-1-[4-(1H-PYRAZOL-4-YL)-PHENYL]-ETHANOL AS MODULATOR OF PROTEIN KINASES

#22 | 2009-12-24
US20090318500A1
Chemistry; metallurgy

4-(2, 6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl)-amide for the Treatment of Cancer

#23 | 2009-01-08
US20090012124A1
Chemistry; metallurgy

4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors

#24 | 2008-06-05
US20080132495A1
Chemistry; metallurgy

Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases

#25 | 2007-09-06
US20070208015A1
Chemistry; metallurgy

5-Morpholinylmethylthiophenyl Pharmaceutical Compounds As P38 MAP Kinase Modulators

InventorID:

154181 ⎘